
IthaID: 3568
Names and Sequences
| Functionality: | Globin gene causative mutation | Pathogenicity: | Pathogenic / Likely Pathogenic | 
|---|---|---|---|
| Common Name: | CD 28 GCC>-CC | HGVS Name: | HBA2:c.85delG | 
| Hb Name: | N/A | Protein Info: | N/A | 
| Also known as: | 
We follow the 
						 
							HGVS sequence variant nomenclature
						
						and
						 
							 IUPAC standards.
						
					
					
					
Context nucleotide sequence:
CACGCTGGCGAGTATGGTGCGGAG [-/G] CCCTGGAGAGGTGAGGCTCCCTCC   (Strand: +)
Comments: Reported in a proband presenting with persistent microcytosis and hypochromia. The deletion of a nt G from codon 28 creates a shift in the reading frame with a premature stop codon at codon 48 (TGA). Residue 28 at the B helix of the α chain is part of the α1β1 interface, which plays a key role in the maintenance of the tertiary structure.
External Links
No available links
Phenotype
| Hemoglobinopathy Group: | Thalassaemia | 
|---|---|
| Hemoglobinopathy Subgroup: | α-thalassaemia | 
| Allele Phenotype: | α⁺ | 
| Associated Phenotypes: | N/A | 
Location
| Chromosome: | 16 | 
|---|---|
| Locus: | NG_000006.1 | 
| Locus Location: | 33860 | 
| Size: | 1 bp | 
| Located at: | α2 | 
| Specific Location: | Exon 1 | 
Other details
| Type of Mutation: | Point-Mutation(Deletion) | 
|---|---|
| Effect on Gene/Protein Function: | Frameshift (Translation) | 
| Ethnic Origin: | Moroccan | 
| Molecular mechanism: | N/A | 
| Inheritance: | Recessive | 
| DNA Sequence Determined: | Yes | 
In silico pathogenicity prediction
Publications / Origin
- Ropero P, Arbeteta J, Nieto JM, González FA, González B, Villegas A, Benavente C, Nondeletional α-Thalassemia: Two New Mutations on the α2 Gene., Hemoglobin, 2020
 
					Created on 2020-02-03 11:50:47,
					Last reviewed on 2022-09-20 09:28:31					(Show full history)
				
				
			
 Disclaimer: The information on this website is provided as an information resource only
    and must not to be used as a substitute for professional diagnosis and treatment.
    The ITHANET Portal and IthaGenes are not responsible or liable for any advice, course of treatment,
    diagnosis or any other information, services or products that an individual obtains through this website.